SCHEMBL10072099

SCHEMBL10072099

Cc1cc(/C=C/C(=O)NOC(C)OCC(C)C)ccc1CNC1(C(=O)OC2CCCC2)CCCCC1

nearest known ligand 0.33

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.33
ALDH1A1 P00352 3/20 0.33
HDAC3 O15379 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
HPGD P15428 1/20 0.33
KDM4E B2RXH2 4/20 0.31
TRPM8 Q7Z2W7 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HDAC4 P56524 1/20 0.31
MEF2D Q14814 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10072243 0.99 MAOB (0.33) MAOBALDH1A1HDAC3HDAC1HDAC2
SCHEMBL10072242 0.98 MAOB (0.33) MAOBALDH1A1HDAC3HDAC1HDAC2
SCHEMBL9895162 0.88 HDAC3 (0.39) ALDH1A1HDAC3HDAC1HDAC2HDAC8
SCHEMBL7896386 0.88 HDAC3 (0.39) ALDH1A1HDAC3HDAC1HDAC2HDAC8
SCHEMBL7897506 0.85 SMN1; SMN2 (0.38) ALDH1A1HDAC3HDAC1HDAC2HDAC8
SCHEMBL9895879 0.85 SMN1; SMN2 (0.38) ALDH1A1HDAC3HDAC1HDAC2HDAC8
SCHEMBL2706546 0.84 HDAC1 (0.46) MAOBHDAC3HDAC1HDAC2HDAC8
SCHEMBL2706542 0.84 HDAC1 (0.46) MAOBHDAC3HDAC1HDAC2HDAC8
SCHEMBL10072275 0.84 MAP3K7 (0.33) HDAC1RAB9ASMN1; SMN2
SCHEMBL2705562 0.83 HDAC1 (0.45) HDAC3HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed